AB0206 Pan-Ppar Agonist IVA337 is Effective in Prevention and Treatment of Experimental Skin Fibrosis von Ruzehaji, N., Frantz, C., Ponsoye, M., Avouac, J., Konstantinova, I., Fromond, C., Broqua, P., Junien, J.L., Allanore, Y.

Volltext

FRI0438 Treatment with Abatacept Prevents Experimental Dermal FIBrosis and Induces Regression of Established Fibrosis in a Preclinical Model of Systemic Sclerosis von Ponsoye, M., Frantz, C., Ruzehaji, N., Elhai, M., Ruiz, B., Cauvet, A., Allanore, Y., Avouac, J.

Volltext

Attenuation of Flightless I, an actin-remodelling protein, improves burn injury repair via modulation of transforming growth factor (TGF)-β1 and TGF-β3 von Adams, D.H., Ruzehaji, N., Strudwick, X.L., Greenwood, J.E., Campbell, H.D., Arkell, R., Cowin, A.J.

Volltext

Attenuation of Flightless I, an actin-remodelling protein, improves burn injury repair via modulation of transforming growth factor (TGF)-beta1 and TGF-beta3 von Adams, D H, Ruzehaji, N, Strudwick, X L, Greenwood, J E, Campbell, H D, Arkell, R, Cowin, A J

Volltext